Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
COVID-19
COVID-19 vaccine
Herpes zoster
Immunization
Meningitis
Post-vaccination
Shingles
varicella-zoster
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
19
10
2021
revised:
04
03
2022
accepted:
27
03
2022
pubmed:
4
4
2022
medline:
18
5
2022
entrez:
3
4
2022
Statut:
ppublish
Résumé
Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization with mRNA COVID-19 vaccines. A few cases have also been reported after viral vector and inactivated COVID-19 vaccination. The incidence of meningitis following varicella zoster virus infection is rare. In the current study, we report two cases of male patients who received two different types of COVID-19 vaccine (inactivated and viral vector) and developed varicella zoster meningitis within 10 days after vaccination.
Identifiants
pubmed: 35367355
pii: S1201-9712(22)00192-8
doi: 10.1016/j.ijid.2022.03.055
pmc: PMC8964532
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Chickenpox Vaccine
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-216Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Cosmet Dermatol. 2021 Jun;20(6):1566-1567
pubmed: 33638924
Psychol Bull. 2004 Jul;130(4):601-30
pubmed: 15250815
Clin Exp Vaccine Res. 2021 May;10(2):198-201
pubmed: 34222134
J Am Acad Dermatol. 2021 Jul;85(1):46-55
pubmed: 33838206
J Cosmet Dermatol. 2021 Nov;20(11):3389-3390
pubmed: 34077622
QJM. 2021 Nov 5;114(7):531-532
pubmed: 34293165
Int J Infect Dis. 2021 Dec;113:55-57
pubmed: 34587536
Sci Rep. 2017 Nov 8;7(1):15039
pubmed: 29118328
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI90-SI95
pubmed: 33848321
J Med Case Rep. 2019 Jun 15;13(1):182
pubmed: 31200772
J Cosmet Dermatol. 2021 Jul;20(7):1960-1964
pubmed: 33991162
PLoS One. 2015 Sep 02;10(9):e0136717
pubmed: 26332995
JAAD Case Rep. 2021 Jun;12:58-59
pubmed: 33937467
Vaccines (Basel). 2021 Jun 01;9(6):
pubmed: 34205861